Find in Library

Lipofilling has gained increased confidence in both esthetic and reconstructive breast surgery. However, in breast carcinoma patients there are some doubts about the crosstalk between adipose tissue microenviroment and cancer tissue. In our case report, a 48-year-old female patient with a heterozygous pathogenic variant in the chromosome 17 BRCA 1 gene had a history of lipofilling after loss of breast prosthesis. The patient presented with the development of triple negative breast carcinoma 20 months after lipofilling application. This case again raises the question about the risk of lipofilling on breast cancer development.